2810405K02Rik Activators
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA acts as a PKC activator, which influences signal transduction pathways that 2810405K02Rik is involved in. Activation of PKC can lead to the phosphorylation of downstream targets that are part of the functional network of 2810405K02Rik, enhancing its activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels. Elevated calcium can activate calcium-dependent kinases and phosphatases, which can then influence the activity of 2810405K02Rik by modifying proteins that interact with or regulate 2810405K02Rik. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as another calcium ionophore, leading to increased intracellular calcium and subsequent activation of calcium-dependent signaling pathways. These pathways can modify the activity state or context of 2810405K02Rik. | ||||||
L-NG-Nitroarginine Methyl Ester (L-NAME) | 51298-62-5 | sc-200333 sc-200333A sc-200333B | 1 g 5 g 25 g | $48.00 $107.00 $328.00 | 45 | |
L-NAME is a nitric oxide synthase inhibitor. By preventing NO production, L-NAME may shift the balance of signaling molecules, affecting the upstream or downstream elements that regulate the functional state of 2810405K02Rik. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter the PI3K/AKT pathway, which is involved in a multitude of cellular processes. By inhibiting this pathway, LY294002 could enhance the activity of 2810405K02Rik if 2810405K02Rik is part of the cellular responses regulated by PI3K/AKT. | ||||||
SB 202190 | 152121-30-7 | sc-202334 sc-202334A sc-202334B | 1 mg 5 mg 25 mg | $31.00 $128.00 $454.00 | 45 | |
SB203580 is a p38 MAPK inhibitor that may enhance 2810405K02Rik activity by inhibiting p38 MAPK and altering the signaling dynamics within the pathways where 2810405K02Rik functions. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits PDE5 and PDE6, leading to increased levels of cGMP. This elevation of cGMP may activate PKG which could then phosphorylate substrates that regulate or are part of the functional processes involving 2810405K02Rik, resulting in its enhanced activity. | ||||||